Figure 1From: Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesTime line. A randomised, double-blind, placebo-controlled, cross-over study with study drug infused for 30 minutes prior to administration of small intestinal nutrient infusion.Back to article page